Stock listing
ARVN Stock Price, News, Filings & Events — Arvinas, Inc.
Selected listing: ARVN · BOATS · USD · US
This page tracks Arvinas, Inc.'s ARVN:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ARVN:BOATS. ARVN:BOATS is the stock-level entry point for investors researching Arvinas, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Arvinas, Inc. is a public company traded under the ticker ARVN on the American market. The company has a market capitalization of approximately $516.8 million. Arvinas focuses on developing innovative therapies for various diseases using its proprietary protein degradation technology.
- Ticker
- ARVN:BOATS
- Asset type
- Stock
- Market cap
- $518.1M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
Arvinas, Inc. ARVN:BOATS stock context
This page tracks Arvinas, Inc.'s ARVN:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ARVN:BOATS. ARVN:BOATS is the stock-level entry point for investors researching Arvinas, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Arvinas, Inc. is a public company traded under the ticker ARVN on the American market. The company has a market capitalization of approximately $516.8 million. Arvinas focuses on developing innovative therapies for various diseases using its proprietary protein degradation technology.
Research Arvinas, Inc.
Arvinas, Inc. investor report
Review AI stock analysis and investor report context for ARVN:BOATS.
Arvinas, Inc. company profile
View the public company page for Arvinas, Inc. on 6ix.
Arvinas, Inc. news
Read company news and market updates connected to Arvinas, Inc..
Arvinas, Inc. investor events
Find investor webinars, events, and replay context for Arvinas, Inc..